Stoke Therapeutics Growth Metrics (2022-2025) | STOK

Growth Metrics Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) 41,244.00-44542.0017,864.00-18883.00-19860.0069,454.0019,853.0090,996.0069,622.0036,368.0017,897.00
EBITDA Margin Growth (3y) 91,005.0061,280.0055,615.00
EBITDA Margin (QoQ) 5,753.00-13222.0014,465.0034,248.00-80033.0049,184.00-22282.0033,271.009,281.00-416.0048,860.0011,897.00-23973.00-18887.00
EBIT Margin Growth (1y) 34,727.00-55955.0011,125.00-22431.00-19373.0073,330.0021,022.0099,551.0074,311.0040,979.0020,776.00
EBIT Margin Growth (3y) 89,665.0058,354.0052,923.00
EBIT Margin (QoQ) 4,538.00-15341.0010,295.0035,235.00-86144.0051,739.00-23261.0038,293.006,559.00-569.0055,268.0013,053.00-26774.00-20771.00
EBT Margin Growth (1y) 38,462.00-47292.0015,714.00-17724.00-18716.0070,533.0020,309.0091,632.0069,756.0036,192.0016,735.00
EBT Margin Growth (3y) 89,503.0059,433.0052,758.00
EBT Margin (QoQ) 5,875.00-13599.0011,395.0034,791.00-79879.0049,406.00-22042.0033,799.009,369.00-817.0049,281.0011,923.00-24195.00-20274.00
Enterprise Value Growth (1y) -76.87%-1.57%-115.85%-75.08%291.42%114.28%1,331.76%996.99%-99.49%-27.15%109.16%
Enterprise Value Growth (3y) -83.31%15.40%59.85%
Enterprise Value (QoQ) -50.92%5.13%-47.21%-15.09%108.87%-116.93%183.00%1,233.50%14.35%-2.67%-26.08%-99.38%16,122.11%179.44%
FCF Margin Growth (1y) -148010.00-25930.0029,572.00-4799.00-15787.0053,446.008,964.0064,236.0066,601.0017,761.0015,692.00
FCF Margin Growth (3y) -97196.0045,278.0054,227.00
FCF Margin (QoQ) -169288.00-19124.0013,200.0027,203.00-47208.0036,377.00-21171.0016,214.0022,025.00-8105.0034,102.0018,579.00-26814.00-10175.00
Net Margin Growth (1y) 38,462.00-47292.0015,714.00-17724.00-18716.0070,533.0020,309.0091,632.0069,676.0036,192.0017,937.00
Net Margin Growth (3y) 89,422.0059,433.0053,960.00
Net Margin (QoQ) 5,875.00-13599.0011,395.0034,791.00-79879.0049,406.00-22042.0033,799.009,369.00-817.0049,281.0011,843.00-24114.00-19072.00
Operating Margin Growth (1y) 34,727.00-55955.0011,125.00-22431.00-19373.0073,330.0021,022.0099,551.0074,311.0040,979.0020,776.00
Operating Margin Growth (3y) 89,665.0058,354.0052,923.00
Operating Margin (QoQ) 4,538.00-15341.0010,295.0035,235.00-86144.0051,739.00-23261.0038,293.006,559.00-569.0055,268.0013,053.00-26774.00-20771.00
Return on Assets Growth (1y) -7.00-13.00-1.007.0013.0065.0054.0046.00
Return on Assets (QoQ) 1.00-2.00-3.00-3.00-5.0010.005.004.0046.00-2.00-2.00
Return on Capital Employed Growth (1y) -12.00-21.00-9.004.0015.0078.0065.0055.00
Return on Capital Employed (QoQ) 0.00-1.00-5.00-6.00-9.0011.007.005.0055.00-2.00-3.00
Return on Equity Growth (1y) -11.00-23.00-2.0013.0024.0090.0069.0057.00
Return on Equity (QoQ) 2.00-2.00-5.00-6.00-9.0018.0010.006.0056.00-2.00-3.00
Return on Sales Growth (1y) 53.00-167.0078.0099.00519.00875.00710.00650.00
Return on Sales (QoQ) 135.00-80.0033.00-34.00-85.00165.0054.00386.00270.000.00-7.00